Novel Fused Bicyclic Compounds as VRK1 Inhibitors for Treating Glioblastoma or Neuroblastoma

This is the authors' abstract. We don't add key points for this paper.

Provided herein are novel fused bicyclic compounds as VRK1 inhibitors, pharmaceutical compositions, use of such compounds in treating glioblastoma or neuroblastoma, and processes for preparing such compounds.